Tendyne Holdings

Tendyne Holdings

Medical device company developing a transcatheter aortic valve implantation system.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round

$250m

Valuation: $250m

Acquisition
Total Funding000k
More about Tendyne Holdings
Made with AI
Edit

Tendyne is a pioneering company in the field of structural heart therapies, specializing in transcatheter mitral valve repair technology. The company operates in the medical device market, primarily serving healthcare providers and patients suffering from mitral regurgitation, a condition where the heart's mitral valve doesn't close tightly, allowing blood to flow backward in the heart. Tendyne's core product, the Tendyne Transcatheter Mitral Valve Implantation (TMVI), offers a minimally invasive solution for patients who are at high surgical risk. This product is designed to improve patient outcomes by providing a less invasive alternative to traditional open-heart surgery. The business model revolves around the development, manufacturing, and distribution of these advanced medical devices, generating revenue through direct sales to hospitals and healthcare facilities. Tendyne's market is global, with a focus on regions where there is a high prevalence of mitral regurgitation and a growing demand for innovative heart therapies. The company leverages clinical data and ongoing trials to continuously improve its products and expand its market reach. Keywords: transcatheter, mitral valve, heart therapies, structural heart, patient care, medical devices, minimally invasive, healthcare, clinical trials, innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads